Pembrolizumab in Combination With Intratumoral SD-101 Therapy
Condition: Prostatic Neoplasms Interventions: Drug: Pembrolizumab; Drug: SD-101; Radiation: High Dose Rate (HDR) Brachytherapy; Other: Combined Androgen Blockage (CAB) Sponsor: Lawrence Fong Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials